搜尋





搜尋





Pliant Therapeutics Inc

PLRX

添加自選

1.130USD

-0.020-1.74%

收盤 09-10 16:00（美東）

70.90M總市值

虧損本益比TTM

盤後交易 (美東)0.000USD0.000

Pliant Therapeutics Inc

1.130

-0.020-1.74%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

PLRX 利潤表

您可以在這裡找到Pliant Therapeutics Inc的年度或季度收入報告，以深入了解Pliant Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

FY2018Q1

營業總收入

----

--0.00

-100.00%0.00

-95.03%248.00K

6.65%1.33M

-1.70%1.96M

-7.95%1.48M

178.87%4.99M

-42.55%1.25M

-55.23%2.00M

-66.56%1.61M

-50.31%1.79M

-92.49%2.17M

--4.46M

--4.81M

--3.60M

--28.94M

--0.00

----

營業收入

----

--0.00

-100.00%0.00

-95.03%248.00K

6.65%1.33M

-1.70%1.96M

-7.95%1.48M

178.87%4.99M

-42.55%1.25M

-55.23%2.00M

-66.56%1.61M

-50.31%1.79M

-92.49%2.17M

--4.46M

--4.81M

--3.60M

--28.94M

--0.00

----

營業費用

-43.04%23.86M

-63.06%21.77M

-55.78%23.58M

-54.58%28.17M

-30.92%41.89M

12.49%58.94M

13.36%53.32M

30.05%62.01M

27.46%60.64M

20.64%52.39M

19.49%47.04M

42.65%47.69M

37.38%47.58M

47.41%43.43M

48.00%39.37M

16.38%33.43M

40.25%34.63M

17.40%29.46M

13.27%26.60M

33.75%28.72M

20.01%24.69M

39.95%25.09M

--23.48M

--21.48M

30.72%20.58M

24.95%17.93M

--15.74M

130.41%14.35M

--6.23M

研發費用

-43.29%16.73M

-68.73%13.58M

-59.83%15.59M

-62.65%17.84M

-35.34%29.50M

16.93%43.44M

16.91%38.79M

47.67%47.75M

38.22%45.62M

26.90%37.15M

32.13%33.18M

31.43%32.34M

25.32%33.00M

40.19%29.27M

33.93%25.11M

16.88%24.61M

37.03%26.34M

12.71%20.88M

5.03%18.75M

24.69%21.05M

9.59%19.22M

33.11%18.53M

--17.85M

--16.88M

33.88%17.54M

18.47%13.92M

--13.10M

134.14%11.75M

--5.02M

折舊攤銷及損耗

-44.30%249.00K

-33.04%300.00K

-12.66%400.00K

-18.05%436.00K

-28.14%447.00K

-12.67%448.00K

-1.29%458.00K

6.40%532.00K

30.40%622.00K

2.60%513.00K

1.98%464.00K

0.00%500.00K

-4.60%477.00K

0.00%500.00K

8.85%455.00K

25.00%500.00K

20.46%418.00K

21.21%400.00K

24.61%400.00K

28.21%400.00K

--347.00K

--330.00K

14.64%321.00K

4.00%312.00K

--280.00K

154.24%300.00K

--118.00K

營業利潤

43.04%-23.86M

63.06%-21.77M

55.78%-23.58M

54.58%-28.17M

30.92%-41.89M

-12.49%-58.94M

-13.36%-53.32M

-30.05%-62.01M

-28.13%-60.64M

-24.46%-52.39M

-25.77%-47.04M

-49.26%-47.69M

-59.67%-47.33M

-49.21%-42.09M

-52.04%-37.40M

-17.83%-31.95M

-29.42%-29.64M

-23.09%-28.21M

-29.36%-24.60M

-62.73%-27.11M

-34.92%-22.90M

-308.20%-22.92M

---19.02M

---16.66M

-7.85%-16.98M

176.71%11.01M

---15.74M

-130.41%-14.35M

---6.23M

淨非營業利息收入（費用）

利息收入

-51.92%1.49M

-51.46%1.73M

-55.59%1.96M

-45.73%2.78M

-45.14%3.10M

-39.34%3.57M

-29.24%4.42M

-21.29%5.13M

-12.42%5.65M

21.08%5.88M

99.58%6.25M

--6.51M

--6.46M

--4.86M

--3.13M

----

--86.00K

--72.00K

-53.75%111.00K

-33.23%209.00K

--240.00K

1856.25%313.00K

--16.00K

利息費用

-100.00%0.00

-83.69%136.00K

-7.07%815.00K

-6.80%809.00K

79.55%799.00K

159.81%834.00K

176.66%877.00K

172.10%868.00K

43.09%445.00K

-59.42%321.00K

--317.00K

--319.00K

--311.00K

--791.00K

----

特殊收入（費用）

----

---1.83M

---100.00K

---3.70M

----

其他非經營性收入（費用）

----

---97.00K

--55.00K

-547.62%-136.00K

-1442.86%-188.00K

---21.00K

240.00%14.00K

---10.00K

稅前利潤

48.33%-22.37M

64.32%-20.04M

52.59%-23.58M

54.47%-26.30M

22.48%-43.30M

-19.62%-56.17M

-20.98%-49.73M

-39.23%-57.76M

-35.59%-55.85M

-25.05%-46.95M

-17.25%-41.11M

-35.51%-41.49M

-39.42%-41.19M

-33.62%-37.55M

-42.92%-35.06M

-13.20%-30.61M

-29.41%-29.55M

-22.94%-28.10M

-28.93%-24.53M

-63.57%-27.05M

-34.29%-22.83M

-307.24%-22.86M

---19.03M

---16.53M

-9.53%-17.00M

178.65%11.03M

---15.52M

-125.38%-14.02M

---6.22M

所得稅

--0.00

----

除稅後利潤

48.33%-22.37M

64.32%-20.04M

52.59%-23.58M

54.47%-26.30M

22.48%-43.30M

-19.62%-56.17M

-20.98%-49.73M

-39.23%-57.76M

-35.59%-55.85M

-25.05%-46.95M

-17.25%-41.11M

-35.51%-41.49M

-39.42%-41.19M

-33.62%-37.55M

-42.92%-35.06M

-13.20%-30.61M

-29.41%-29.55M

-22.94%-28.10M

-28.93%-24.53M

-63.57%-27.05M

-34.29%-22.83M

-307.24%-22.86M

---19.03M

---16.53M

-9.53%-17.00M

178.65%11.03M

---15.52M

-125.38%-14.02M

---6.22M

持續經營利潤

48.33%-22.37M

64.32%-20.04M

52.59%-23.58M

54.47%-26.30M

22.48%-43.30M

-19.62%-56.17M

-20.98%-49.73M

-39.23%-57.76M

-35.59%-55.85M

-25.05%-46.95M

-17.25%-41.11M

-35.51%-41.49M

-39.42%-41.19M

-33.62%-37.55M

-42.92%-35.06M

-13.20%-30.61M

-29.41%-29.55M

-22.94%-28.10M

-28.93%-24.53M

-63.57%-27.05M

-34.29%-22.83M

-307.24%-22.86M

---19.03M

---16.53M

-9.53%-17.00M

178.65%11.03M

---15.52M

-125.38%-14.02M

---6.22M

歸属于母公司的淨利潤

48.33%-22.37M

64.32%-20.04M

52.59%-23.58M

54.47%-26.30M

22.48%-43.30M

-19.62%-56.17M

-20.98%-49.73M

-39.23%-57.76M

-35.59%-55.85M

-25.05%-46.95M

-17.25%-41.11M

-35.51%-41.49M

-39.42%-41.19M

-33.62%-37.55M

-42.92%-35.06M

-13.20%-30.61M

-29.41%-29.55M

-22.94%-28.10M

-28.93%-24.53M

-63.57%-27.05M

-34.29%-22.83M

---22.86M

---19.03M

---16.53M

-0.71%-17.00M

100.00%0.00

---16.88M

-116.31%-15.37M

---7.10M

優先股派息

----

--0.00

----

--0.00

-100.00%0.00

--1.36M

52.38%1.34M

--882.00K

歸屬普通股東的淨利潤

48.33%-22.37M

64.32%-20.04M

52.59%-23.58M

54.47%-26.30M

22.48%-43.30M

-19.62%-56.17M

-20.98%-49.73M

-39.23%-57.76M

-35.59%-55.85M

-25.05%-46.95M

-17.25%-41.11M

-35.51%-41.49M

-39.42%-41.19M

-33.62%-37.55M

-42.92%-35.06M

-13.20%-30.61M

-29.41%-29.55M

-22.94%-28.10M

-28.93%-24.53M

-63.57%-27.05M

-34.29%-22.83M

---22.86M

---19.03M

---16.53M

-0.71%-17.00M

100.00%0.00

---16.88M

-116.31%-15.37M

---7.10M

基本每股收益

48.78%-0.36

64.66%-0.32

53.05%-0.38

54.97%-0.43

23.74%-0.71

-17.58%-0.92

-19.11%-0.82

-36.84%-0.95

-32.88%-0.93

-16.49%-0.78

4.39%-0.69

-6.25%-0.70

14.77%-0.70

13.91%-0.67

-5.38%-0.72

13.15%-0.65

-27.89%-0.82

-21.34%-0.78

-27.40%-0.68

-61.47%-0.75

-28.48%-0.64

---0.64

---0.53

---0.47

-0.71%-0.50

100.00%0.00

---0.49

-116.32%-0.45

---0.21

稀釋每股收益

48.78%-0.36

64.66%-0.32

53.05%-0.38

54.97%-0.43

23.74%-0.71

-17.58%-0.92

-19.11%-0.82

-36.84%-0.95

-32.88%-0.93

-16.49%-0.78

4.39%-0.69

-6.25%-0.70

14.77%-0.70

13.91%-0.67

-5.38%-0.72

13.15%-0.65

-27.89%-0.82

-21.34%-0.78

-27.40%-0.68

-61.47%-0.75

-28.48%-0.64

---0.64

---0.53

---0.47

-0.71%-0.50

100.00%0.00

---0.49

-116.32%-0.45

---0.21

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Pliant Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 PLRX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Pliant Therapeutics Inc 全年的淨利潤是多少？



Pliant Therapeutics Inc 2025 財年淨利潤為 -149.34M。

Pliant Therapeutics Inc 上一季度的淨利潤是多少？



Pliant Therapeutics Inc 最近一個季度的淨利潤為 -22.37M。

Pliant Therapeutics Inc 年度營業利潤是多少？



Pliant Therapeutics Inc 2025 財年的營業利潤為 -152.57M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。